Barclays’s Elanco Animal Health ELAN Stock Holding History

Barclays’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-260,000	Closed	-$3.82M	–	5329
2024 Q3	$3.82M	Buy	+260,000	New	+$3.62M	﹤0.01%	2307
2024 Q2	–	Sell	-30,000	Closed	-$488K	–	4989
2024 Q1	$488K	Hold	30,000	–	–	﹤0.01%	3609
2023 Q4	$447K	Buy	+30,000	New	+$340K	﹤0.01%	3947
2021 Q1	–	Sell	-200	Closed	-$6K	–	4817
2020 Q4	$6K	Hold	200	–	–	﹤0.01%	4776
2020 Q3	$6K	Sell	200 -9,400	-98%	-$238K	﹤0.01%	5053
2020 Q2	$206K	Sell	9,600 -223,000	-96%	-$4.93M	﹤0.01%	4049
2020 Q1	$5.21M	Buy	232,600 +169,100	+266%	+$4.63M	﹤0.01%	1426
2019 Q4	$1.87M	Sell	63,500 -3,200	-5%	-$87K	﹤0.01%	3076
2019 Q3	$1.77M	Buy	66,700 +50,200	+304%	+$1.51M	﹤0.01%	3015
2019 Q2	$558K	Buy	16,500 +16,400	+16,400%	+$532K	﹤0.01%	4221
2019 Q1	$3K	Sell	100 -4,200	-98%	-$129K	﹤0.01%	6792
2018 Q4	$136K	Buy	+4,300	New	+$141K	﹤0.01%	4840

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Barclays's ELAN Position: Q1 2026 in Review

Barclays reduced its Elanco Animal Health (ELAN) stake by 35% in Q1 2026, selling an estimated $3.52M and leaving 267,582 shares worth $6.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

Barclays first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $29M in Q3 2021. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Barclays held 267,582 shares of Elanco Animal Health worth $6.4M as of Q1 2026.
Barclays sold 143,903 Elanco Animal Health shares in Q1 2026, an estimated $3.52M.
Elanco Animal Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1674 holding.
Barclays first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
Barclays's Elanco Animal Health position peaked at $29M in Q3 2021.
516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.